Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania

Original language	English
Pages (from-to)	e1489-e1490
Journal	The Lancet Global Health
Volume	9
Issue number	11
Early online date	13 Oct 2021
DOIs	https://doi.org/10.1016/S2214-109X(21)00402-2
Publication status	Published - 01 Nov 2021

Access to Document

• 10.1016/S2214-109X(21)00402-2Licence: CC BY-NC-ND

• Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania

  Copyright 2021 the authors. This is an open access article published under a Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits distribution and reproduction for non-commercial purposes, provided the author and source are cited.

  Final published version, 53.4 KBLicence: CC BY-NC-ND

Student theses

• Tools to support data-driven identification and management of glaucoma in Sub-Saharan Africa

  Author: Olawoye, O. O., Dec 2023

  Supervisor: Congdon, N. (Supervisor), Azuara-Blanco, A. (Supervisor) & Chan, V. F. (Supervisor)

  Student thesis: Doctoral Thesis › Doctor of Philosophy

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Olawoye, O., & Etya'ale, D. (2021). Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania. The Lancet Global Health, 9(11), e1489-e1490. https://doi.org/10.1016/S2214-109X(21)00402-2

Olawoye, Olusola ; Etya'ale, Daniel. / Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania. In: The Lancet Global Health. 2021 ; Vol. 9, No. 11. pp. e1489-e1490.

@article{5ec17acd16ad458980c8404659c98aff,

title = "Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania",

author = "Olusola Olawoye and Daniel Etya'ale",

year = "2021",

month = nov,

day = "1",

doi = "10.1016/S2214-109X(21)00402-2",

language = "English",

volume = "9",

pages = "e1489--e1490",

journal = "The Lancet Global Health",

issn = "2214-109X",

publisher = "Elsevier BV",

number = "11",

}

Olawoye, O & Etya'ale, D 2021, 'Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania', The Lancet Global Health, vol. 9, no. 11, pp. e1489-e1490. https://doi.org/10.1016/S2214-109X(21)00402-2

Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania. / Olawoye, Olusola; Etya'ale, Daniel.

In: The Lancet Global Health, Vol. 9, No. 11, 01.11.2021, p. e1489-e1490.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania

AU - Olawoye, Olusola

AU - Etya'ale, Daniel

PY - 2021/11/1

Y1 - 2021/11/1

U2 - 10.1016/S2214-109X(21)00402-2

DO - 10.1016/S2214-109X(21)00402-2

M3 - Comment/debate

C2 - 34655546

VL - 9

SP - e1489-e1490

JO - The Lancet Global Health

JF - The Lancet Global Health

SN - 2214-109X

IS - 11

ER -

Olawoye O, Etya'ale D. Selective laser trabeculoplasty versus 0·5% timolol eye drops in the management of glaucoma in Tanzania. The Lancet Global Health. 2021 Nov 1;9(11):e1489-e1490. Epub 2021 Oct 13. doi: 10.1016/S2214-109X(21)00402-2